Dietary Omega-3 Fatty Acid Dampens Allergic Rhinitis via Eosinophilic Production of the Anti-Allergic Lipid Mediator 15-Hydroxyeicosapentaenoic Acid in Mice.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
22 11 2019
Historique:
received: 19 10 2019
revised: 13 11 2019
accepted: 18 11 2019
entrez: 27 11 2019
pubmed: 27 11 2019
medline: 26 6 2020
Statut: epublish

Résumé

The metabolism and generation of bioactive lipid mediators are key events in the exertion of the beneficial effects of dietary omega-3 fatty acids in the regulation of allergic inflammation. Here, we found that dietary linseed oil, which contains high amounts of alpha-linolenic acid (ALA) dampened allergic rhinitis through eosinophilic production of 15-hydroxyeicosapentaenoic acid (15-HEPE), a metabolite of eicosapentaenoic acid (EPA). Lipidomic analysis revealed that 15-HEPE was particularly accumulated in the nasal passage of linseed oil-fed mice after the development of allergic rhinitis with the increasing number of eosinophils. Indeed, the conversion of EPA to 15-HEPE was mediated by the 15-lipoxygenase activity of eosinophils. Intranasal injection of 15-HEPE dampened allergic symptoms by inhibiting mast cell degranulation, which was mediated by the action of peroxisome proliferator-activated receptor gamma. These findings identify 15-HEPE as a novel EPA-derived, and eosinophil-dependent anti-allergic metabolite, and provide a preventive and therapeutic strategy against allergic rhinitis.

Identifiants

pubmed: 31766714
pii: nu11122868
doi: 10.3390/nu11122868
pmc: PMC6950470
pii:
doi:

Substances chimiques

Anti-Allergic Agents 0
PPAR gamma 0
Linseed Oil 8001-26-1
15-hydroxy-5,8,11,13,17-eicosapentaenoic acid 97850-14-1
Eicosapentaenoic Acid AAN7QOV9EA

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)/Japanese Society for the Promotion of Science KAKENHI
ID : JP19K07617, JP18K17997, JP15H05790, JP17K09604, JP18H02150, JP18H02674
Pays : International
Organisme : the Japan Agency for Medical Research and Development
ID : JP17ek0410032s0102, JP17ek0210078h0002, JP17ak0101068h0001, JP19ek0410062h0001
Pays : International
Organisme : the Ministry of Health, Labour, and Welfare of Japan
ID : JP19KA3001
Pays : International
Organisme : the Ministry of Health and Welfare of Japan
ID : -
Pays : International
Organisme : the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry
ID : -
Pays : International
Organisme : the Ono Medical Research Foundation
ID : -
Pays : International
Organisme : the Canon Foundation
ID : -
Pays : International

Références

Mucosal Immunol. 2013 Nov;6(6):1119-30
pubmed: 23462912
J Immunol. 2007 Nov 1;179(9):5897-906
pubmed: 17947663
Allergy. 2019 Aug;74(8):1429-1444
pubmed: 31032983
J Allergy Clin Immunol. 2014 May;133(5):1255-64
pubmed: 24613565
Lab Invest. 2016 Sep;96(9):981-93
pubmed: 27322954
Allergol Int. 2017 Apr;66(2):205-219
pubmed: 28214137
J Exp Med. 2005 Mar 7;201(5):713-22
pubmed: 15753205
J Allergy Clin Immunol. 2003 May;111(5):1049-61
pubmed: 12743570
J Clin Invest. 2016 Sep 1;126(9):3279-95
pubmed: 27548519
Int Immunol. 2019 Aug 23;31(9):559-567
pubmed: 30772915
Allergy. 2008 Sep;63(9):1136-47
pubmed: 18547288
J Exp Med. 2018 Aug 6;215(8):2055-2072
pubmed: 29970473
Eur J Pharmacol. 2016 Aug 15;785:174-186
pubmed: 27041644
Allergy. 2012 Apr;67(4):502-9
pubmed: 22257110
Lipids Health Dis. 2019 Jan 18;18(1):16
pubmed: 30658644
Sci Rep. 2015 Aug 14;5:13127
pubmed: 26272420
Allergol Int. 2009 Jun;58(2):247-53
pubmed: 19307774
J Exp Med. 1983 Jun 1;157(6):1981-91
pubmed: 6854212
Allergol Int. 2016 Sep;65 Suppl:S2-5
pubmed: 27371965
Adv Nutr. 2015 Sep 15;6(5):513-40
pubmed: 26374175
FASEB J. 2011 Feb;25(2):561-8
pubmed: 20959515
J Allergy Clin Immunol. 2018 Aug;142(2):470-484.e12
pubmed: 29288079
J Exp Med. 2014 Jul 28;211(8):1673-87
pubmed: 25049337
FASEB J. 2019 Mar;33(3):3392-3403
pubmed: 30383446
J Endocrinol. 2014 Jan 15;220(2):T61-79
pubmed: 24323910
J Allergy Clin Immunol. 2017 Oct;140(4):950-958
pubmed: 28602936
J Exp Med. 2000 Oct 16;192(8):1197-204
pubmed: 11034610
Allergy. 2013 Feb;68(2):171-9
pubmed: 23205534
Allergy. 2018 Feb;73(2):369-378
pubmed: 28857178
Allergy. 2019 Aug;74(8):1522-1532
pubmed: 30843234
J Biol Chem. 2012 Mar 23;287(13):10525-34
pubmed: 22275352
PLoS One. 2014 Mar 06;9(6):e90638
pubmed: 24603700
J Allergy Clin Immunol. 2013 Feb;131(2):353-60.e1-2
pubmed: 23006546
Int Immunol. 2019 Aug 23;31(9):569-577
pubmed: 30722032
Cytotechnology. 2013 Dec;65(6):899-907
pubmed: 23138267
Nat Rev Immunol. 2017 Dec;17(12):746-760
pubmed: 28891557
Bio Protoc. 2014 Jun 20;4(12):
pubmed: 27540562
Nat Med. 2012 May 04;18(5):693-704
pubmed: 22561833
Nat Immunol. 2008 Aug;9(8):873-9
pubmed: 18568027
J Immunol. 2011 Apr 1;186(7):4253-62
pubmed: 21357262
Sci Rep. 2018 May 21;8(1):7954
pubmed: 29784972
Hypertension. 2014 Jul;64(1):53-9
pubmed: 24777981
Clin Exp Allergy. 2019 Jun;49(6):799-807
pubmed: 30689281
Mol Med Rep. 2017 Aug;16(2):1793-1800
pubmed: 28656266
Sci Rep. 2015 Jun 11;5:9750
pubmed: 26065911
Sci Rep. 2013;3:1540
pubmed: 23528921
N Engl J Med. 2015 Nov 5;373(19):1885-6
pubmed: 26535528
Nat Commun. 2012;3:1034
pubmed: 22948816
Int Arch Allergy Immunol. 2015;168(4):219-32
pubmed: 26855055
Allergy. 2019 Jun;74(6):1113-1124
pubmed: 30667533
Nature. 2007 Jun 14;447(7146):869-74
pubmed: 17568749
Front Immunol. 2019 Jan 17;9:3131
pubmed: 30705676

Auteurs

Kento Sawane (K)

Nippon Flour Mills Co., Ltd., Innovation Center, Kanagawa 243-0041, Japan.
Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.
Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.

Takahiro Nagatake (T)

Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.

Koji Hosomi (K)

Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.

So-Ichiro Hirata (SI)

Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.
Department of Microbiology and Immunology, Kobe University Graduate School of Medicine, Hyogo 650-0017, Japan.

Jun Adachi (J)

Laboratory of Proteome Research, NIBIOHN, Osaka 567-0085, Japan.

Yuichi Abe (Y)

Division of Molecular Diagnosis, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan.

Junko Isoyama (J)

Laboratory of Proteome Research, NIBIOHN, Osaka 567-0085, Japan.

Hidehiko Suzuki (H)

Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.

Ayu Matsunaga (A)

Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.

Satoshi Fukumitsu (S)

Nippon Flour Mills Co., Ltd., Innovation Center, Kanagawa 243-0041, Japan.
Collaborative Graduate School Program, University of Tsukuba, Ibaraki 305-8577, Japan.

Kazuhiko Aida (K)

Nippon Flour Mills Co., Ltd., Innovation Center, Kanagawa 243-0041, Japan.

Takeshi Tomonaga (T)

Laboratory of Proteome Research, NIBIOHN, Osaka 567-0085, Japan.

Makoto Arita (M)

Division of Physiological Chemistry and Metabolism, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo 105-8512, Japan.
Laboratory for Metabolomics, RIKEN Center for Integrative Medical Sciences, Kanagawa 230-0045, Japan.
Cellular and Molecular Epigenetics Laboratory, Graduate School of Medical Life Science, Yokohama City University, Kanagawa 230-0045, Japan.

Jun Kunisawa (J)

Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.
Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
Department of Microbiology and Immunology, Kobe University Graduate School of Medicine, Hyogo 650-0017, Japan.
Graduate School of Medicine and Graduate School of Dentistry, Osaka University, Osaka 565-0871, Japan.
Division of Mucosal Immunology, Department of Microbiology and Immunology and International Research and Development Center for Mucosal Vaccines, the Institute of Medical Science, the University of Tokyo, Tokyo 108-8639, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH